NCT03667963

Brief Summary

This study evaluates the effect of different methods of preparation (cooked and consumed hot vs cooked, cooled overnight and consumed cold) and variation in the activity of salivary amylase on the glycemic index and carbohydrate digestibility in healthy human subjects. The effect of genetic variation in small intestinal starch digesting enzymes on glycemic index and starch digestibility will also be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 29, 2018

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2018

Completed
Last Updated

January 11, 2019

Status Verified

January 1, 2019

Enrollment Period

4 months

First QC Date

September 10, 2018

Last Update Submit

January 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glycemic Index (GI)

    For each subject, the incremental area under the glucose response curve over 2 hours (iAUC) after each rice test meal is expressed as a percentage of the mean iAUC elicited by the 2 glucose test meals.

    0-2 hours

Secondary Outcomes (3)

  • Carbohydrate malabsorbed

    0-6 hours.

  • Glycemic response

    0-2 hours

  • Breath hydrogen response

    0-6 hours

Study Arms (2)

Low Salivary Amylase Activity

OTHER

Glucose Glucose plus lactulose Hot Rice Cold Rice

Other: GlucoseOther: Glucose plus lactuloseOther: Hot RiceOther: Cold Rice

High Salivary Amylase Activity

OTHER

Glucose Glucose plus lactulose Hot Rice Cold Rice

Other: GlucoseOther: Glucose plus lactuloseOther: Hot RiceOther: Cold Rice

Interventions

GlucoseOTHER

50g glucose dissolved in 250ml water

High Salivary Amylase ActivityLow Salivary Amylase Activity

50g glucose plus 10g lactulose dissolved in 250ml water

High Salivary Amylase ActivityLow Salivary Amylase Activity

Freshly cooked polished rice containing 50g available carbohydrate (approximately 2/3 cup cooked rice) and consumed hot.

High Salivary Amylase ActivityLow Salivary Amylase Activity

Cooked polished rice containing 50g available carbohydrate (approximately 2/3 cup cooked rice) cooled overnight in a refrigerator and consumed cold.

High Salivary Amylase ActivityLow Salivary Amylase Activity

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males or non-pregnant females aged 18-75 years and in good health
  • Eligible to receive income in Canada
  • Have Ontario Health Insurance Plan or equivalent medical coverage.
  • Previous donor of saliva using protocol reference number # 31093 or GIL-1670 (in which subject consents to measurement of salivary amylase activity and genetic variation in AMY1, SI and MGAM genes).
  • Salivary amylase activity in the lowest tertile (\<50 U/ml) or highest tertile (\>105 U/ml) of salivary amylase activity of 40 subjects previously measured.

You may not qualify if:

  • known history of AIDS, hepatitis, diabetes or a heart condition
  • Allergy to rice, canola oil or sesame oil.
  • use of medications (including, but not limited to, insulin or other antidiabetic drugs, systemic steroids, antipsychotics, protease inhibitors, antivirals, immunosuppressive agents and drugs affecting gut motility or digestion) or with any condition which might, in the opinion of Dr. Wolever, the Medical Director or GI Labs, either: 1) make participation dangerous to the participant himself (or herself) or to others, or 2) affect the results.
  • individuals who cannot or will not comply with the experimental procedures or do not follow the instructions of GI Labs staff related to the safe performance of the experimental procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glycemic Index Laboratories

Toronto, Ontario, M5C 2X3, Canada

Location

Related Publications (1)

  • Wolever TMS, El-Sohemy A, Ezatagha A, Zurbau A, Jenkins AL. Neither low salivary amylase activity, cooling cooked white rice, nor single nucleotide polymorphisms in starch-digesting enzymes reduce glycemic index or starch digestibility: a randomized, crossover trial in healthy adults. Am J Clin Nutr. 2021 Nov 8;114(5):1633-1645. doi: 10.1093/ajcn/nqab228.

MeSH Terms

Conditions

Glucose-Galactose Malabsorption

Interventions

GlucoseLactulose

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydratesDisaccharidesOligosaccharidesPolysaccharides

Study Officials

  • Thomas MS Wolever, MD, PhD

    President, Medical Director

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 10, 2018

First Posted

September 12, 2018

Study Start

August 29, 2018

Primary Completion

December 21, 2018

Study Completion

December 21, 2018

Last Updated

January 11, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations